Drug Stocks March 2026: Top 3 Picks for Growth and Safety
In March 2026, the drug stock landscape blends steady demand with ongoing innovation. This article highlights three c...
Tax harvesting to lower capital gains automates selling decisions to reduce taxes while maintaining portfolio goals.
25,625 articlesIn March 2026, the drug stock landscape blends steady demand with ongoing innovation. This article highlights three c...
OpenAI’s IPO-style risk disclosure confirms Microsoft’s central role in its operations, signaling potential leverage ...
PayPal reports a solid quarter but the stock falls as the company commits to an AI-driven reorganization. The legacy ...
Dream Finders' unsolicited cash offer values Beazer at about $704 million, sparking a public contest as U.S. homebuil...
Institutional investors are loading up on two beaten-down software giants as AI infrastructure demand remains solid a...
Broadcom and Microsoft posted AI-driven quarters, underscoring two distinct strategies: Broadcom sells AI chips to hy...
The Vatican has established a dedicated AI commission as Pope Leo XIV prepares a papal encyclical on AI ethics with A...
Tesla stock can swing on headlines and catalysts. This guide shows you how to decide whether you should wait tesla st...
Two crypto treasury desks, Sharplink and Forward, are joining Russell’s U.S. index family, signaling growing mainstre...
Regulators are tightening control over cash-to-crypto channels as Bitcoin ATMs—the devices that brought crypto into e...
SpaceX is exploring an IPO designed for everyday investors, outlining a plan to list shares and fund its space infras...
Is Byrna Technologies the next big opportunity in non-lethal protection? This analysis breaks down the growth case, k...